Wide Cytokine Analysis in Cerebrospinal Fluid at Diagnosis Identified CCL-3 as a Possible Prognostic Factor for Multiple Sclerosis-Reference-Cited by-同舟云学术

Wide Cytokine Analysis in Cerebrospinal Fluid at Diagnosis Identified CCL-3 as a Possible Prognostic Factor for Multiple Sclerosis

Published:2020-03-05 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Puthenparampil Marco,Stropparo Erica,Zywicki Sofia,Bovis Francesca,Cazzola Chiara,Federle Lisa,Grassivaro Francesca,Rinaldi Francesca,Perini Paola,Sormani Maria Pia,Gallo Paolo

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. The relation between inflammation and neurodegeneration in multiple sclerosis brains;Frischer;Brain.,2009

2. Multiple sclerosis;Thompson;Lancet.,2018

3. Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients;Fitzner;Autoimmun Rev.,2015

4. Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future;Raphael;Expert Rev Clin Immunol.,2015

5. The value of oligoclonal bands in the multiple sclerosis diagnostic criteria;Arrambide;Brain.,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute blood loss in mice forces differentiation of both CD45-positive and CD45-negative erythroid cells and leads to a decreased CCL3 chemokine production by bone marrow erythroid cells;PLOS ONE;2024-09-04

2. Blood-brain barrier damage associates with glia-related cytokines in the cerebrospinal fluid of patients with Multiple Sclerosis;Multiple Sclerosis and Related Disorders;2024-02

3. Bruton tyrosine kinase inhibitors: can they be optimized for the treatment of neuroinflammatory disorders?;Expert Opinion on Investigational Drugs;2023-12-02

4. TNF-α/STAT1/CXCL10 mutual inflammatory axis that contributes to the pathogenesis of experimental models of multiple sclerosis: A promising signaling pathway for targeted therapies;Cytokine;2023-08

5. New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine;Cellular & Molecular Immunology;2023-05-17